Landmark international study: CAR T-cell therapy safe and effective in youth with leukemia

Results of the global, multicenter, pivotal phase 2 study that led to the first FDA approval of a gene therapy/cell therapy approach known as CAR T-cell therapy, were published today in the New England Journal of Medicine.

Read more: https://eurekalert.org/pub_releases/2018-01/chla-lis013018.php